Alternatives to Aiomics

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-powered platform for designing novel molecular structures for new medicines.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Life science company pioneering drug discovery with AI and advanced technologies.

AI-driven platform for protein-level disease mapping and drug discovery.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Compressing biology to develop the next generation of therapies.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Computational biology company revolutionizing life sciences product discovery and development using predictive biology.

Drug development company creating first-in-class RNA-targeting therapeutics using a proprietary platform.